MAYER ELDON C. III sold 7.3% of their position (4.39K shares) of EIGER BIOPHARMACEUTICALS, INC. on the open market
Open‑market sale worth $4.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/21/2023ACC: 0001140361-23-012884
Director
Since Nov 2018
-4.39K
Net shares
Net seller
$4.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
4.39K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.52K
Price / share
$1.07
Trade value
$2.70K
% of position
4.2%
3/17/2023
60.47K→57.95K
Common Stock
Direct
Shares
−1.88K
Price / share
$1.07
Trade value
$2.01K
% of position
3.2%
3/17/2023
57.95K→56.07K
Total
Net shares
−4.39K
Net value
-$4.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2023 | S · Sale | −2.52K | $1.07 | $2.70K | 4.2% | 60.47K | 57.95K |
| Common Stock Direct | 3/17/2023 | S · Sale | −1.88K | $1.07 | $2.01K | 3.2% | 57.95K | 56.07K |
| Total | −4.39K | -$4.70K | ||||||
Derivative Transactions0
No derivative transactions reported